复方皂矾丸治疗再生障碍性贫血临床疗效评价

A Clinical Observation of Compound Zaofan Pill For Aplastic Anemia

【目的】探讨复方皂矾丸 (西洋参、海马、皂矾等组成 )对再生障碍性贫血的临床疗效。【方法】采用前瞻性随机对照方法 ,观察复方皂矾丸加康力龙联合治疗 36例再生障碍性贫血患者血红蛋白、白细胞、血小板上升变化情况。【结果】复方皂矾丸联合治疗组总有效率为 86 % ,明显高于基础治疗组的 53.5%(两组比较P <0 .0 0 5)。【结论】复方皂矾丸是治疗再生障碍性贫血安全、廉价、效果满意的药物。

Objective To assess the therapeutic ef fects of Compound Zaofan Pill (CZP) on aplastic anemia (AA). Methods A prospective randomized control trial was carried out. Thirty_six cases of AA treated with C ZP combined with stanozolol were allocated to Group A and other 30 cases treated with levamisole, prednisone, stanozolol and folacin served as Group B. Hemoglob in content, leukocyte and platelet counts were detected. Results The total e ffective rate was higher in G roup A (86%) than that in Group B ( 53.5% ), the differences bein g significant (P< 0.005 ). Conclusion CZP is an effective and cheap drug for the treatment of AA.